Itzik Cooper

Dr. Itzik Cooper

The Joseph Sagol Neuroscience Center, Sheba Medical Center, Tel Hashomer, Ramat-Gan 52621, Israel
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Biomaterials
Verified
Journal Article
Closed access
SSShahar Shelly
Shahar Shelly
SZSigal Liraz Zaltsman
Sigal Liraz Zaltsman
OBOfir Ben-Gal
Ofir Ben-Gal
ADAvraham Dayan
Avraham Dayan
IGIthamar Ganmore
Ithamar Ganmore
ICItzik Cooper
Itzik Cooper

9 September 2020 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
HIHila Israelov
Hila Israelov
OROrly Ravid
Orly Ravid
DADana Atrakchi
Dana Atrakchi
DRDaniel Rand
Daniel Rand
SEShirin Elhaik
Shirin Elhaik
ICItzik Cooper
Itzik Cooper
Background: Excessive inflammation might activate and injure the blood-brain barrier (BBB), a common feature of many central nervous system (CNS) disorders. We previously developed an in vitro BBB injury model in which the organophosphate paraoxon (PX) affects the BBB endothelium by attenuating junctional protein expression leading to weakened barrier integrity. The objective of this study was to investigate the inflammatory cellular response at the BBB to elucidate critical pathways that might lead to effective treatment in CNS pathologies in which the BBB is compromised. We hypothesized that caspase-1, a core component of the inflammasome complex, might have important role in BBB function since accumulating evidence indicates its involvement in brain inflammation and pathophysiology.Methods: An in vitro human BBB model was employed to investigate BBB functions related to inflammation, primarily adhesion and transmigration of peripheral blood mononuclear cells (PBMCs). Caspase-1 pathway was studied by measurements of its activation state and its role in PBMCs adhesion, transmigration, and BBB permeability were investigated using the specific caspase-1 inhibitor, VX-765. Expression level of adhesion and junctional molecules and the secretion of pro-inflammatory cytokines were measured in vitro and in vivo at the BBB endothelium after exposure to PX. The potential repair effect of blocking caspase-1 and downstream molecules was evaluated by immunocytochemistry, ELISA, and Nanostring technology.Results: PX affected the BBB in vitro by elevating the expression of the adhesion molecules E-selectin and ICAM-1 leading to increased adhesion of PBMCs to endothelial monolayer, followed by elevated transendothelial-migration which was ICAM-1 and LFA-1 dependent. Blocking caspase-8 and 9 rescued the viability of the endothelial cells but not the elevated transmigration of PBMCs. Inhibition of caspase-1, on the other hand, robustly restored all of barrier insults tested including PBMCs adhesion and transmigration, permeability, and VE-cadherin protein levels. The in vitro inflammatory response induced by PX and the role of caspase-1 in BBB injury were corroborated in vivo in isolated blood vessels from hippocampi of mice exposed to PX and treated with VX-765.Conclusions: These results shed light on the important role of caspase-1 in BBB insult in general and specifically in the inflamed endothelium, and suggest therapeutic potential for various CNS disorders, by targeting caspase-1 in the injured BBB.

28 February 2021 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
DRDaniel Rand
Daniel Rand
OROrly Ravid
Orly Ravid
DADana Atrakchi
Dana Atrakchi
HIHila Israelov
Hila Israelov
YBYael Bresler
Yael Bresler
ICItzik Cooper
Itzik Cooper
The objective of this study was to investigate the molecular response to damage at the blood-brain barrier (BBB) and to elucidate critical pathways that might lead to effective treatment in central nervous system (CNS) pathologies in which the BBB is compromised. We have used a human, stem-cell derived in-vitro BBB injury model to gain a better understanding of the mechanisms controlling BBB integrity. Chemical injury induced by exposure to an organophosphate resulted in rapid lipid peroxidation, initiating a ferroptosis-like process. Additionally, mitochondrial ROS formation (MRF) and increase in mitochondrial membrane permeability were induced, leading to apoptotic cell death. Yet, these processes did not directly result in damage to barrier functionality, since blocking them did not reverse the increased permeability. We found that the iron chelator, Desferal© significantly decreased MRF and apoptosis subsequent to barrier insult, while also rescuing barrier integrity by inhibiting the labile iron pool increase, inducing HIF2α expression and preventing the degradation of Ve-cadherin specifically on the endothelial cell surface. Moreover, the novel nitroxide JP4-039 significantly rescued both injury-induced endothelium cell toxicity and barrier functionality. Elucidating a regulatory pathway that maintains BBB integrity illuminates a potential therapeutic approach to protect the BBB degradation that is evident in many neurological diseases.

16 October 2018 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
OROrly Ravid
Orly Ravid
SGShirin Elhaik Goldman
Shirin Elhaik Goldman
DMDavid Macheto
David Macheto
YBYael Bresler
Yael Bresler
RORaquel Ines De Oliveira
Raquel Ines De Oliveira
ICItzik Cooper
Itzik Cooper
Organophosphorus compounds (OPs) are highly toxic chemicals widely used as pesticides (e.g., paraoxon (PX)- the active metabolite of the insecticide parathion) and as chemical warfare nerve agents. Blood-brain barrier (BBB) leakage has been shown in rodents exposed to PX, which is an organophosphate oxon. In this study, we investigated the cellular mechanisms involved in BBB reaction after acute exposure to PX in an established in vitro BBB system made of stem-cell derived, human brain-like endothelial cells (BLECs) together with brain pericytes that closely mimic the in vivo BBB. Our results show that PX directly affects the BBB in vitro both at toxic and non-toxic concentrations by attenuating tight junctional (TJ) protein expression and that only above a certain threshold the paracellular barrier integrity is compromised. Below this threshold, BLECs exhibit a morphological coping mechanism in which they enlarge their cell area thus preventing the formation of meaningful intercellular gaps and maintaining barrier integrity. Importantly, we demonstrate that reversal of the apoptotic cell death induced by PX, by a pan-caspase-inhibitor ZVAD-FMK (ZVAD) can reduce PX-induced cell death and elevate cell area but do not prevent the induced BBB permeability, implying that TJ complex functionality is hindered. This is corroborated by formation of ROS at all toxic concentrations of PX and which are even higher with ZVAD. We suggest that while lower levels of ROS can induce compensating mechanisms, higher PX-induced oxidative stress levels interfere with barrier integrity.

30 November 2022 in Nutrients
Verified
Journal Article
Open access
PDF file
Alicia Isabel Leikin FrenkelAlicia Isabel Leikin Frenkel
Alicia Isabel Leikin Frenkel
MBMichal Schnaider Beeri
Michal Schnaider Beeri
ICItzik Cooper
Itzik Cooper
Cognitive decline, the primary clinical phenotype of Alzheimer’s disease (AD), is currently attributed mainly to amyloid and tau protein deposits. However, a growing body of evidence is converging on brain lipids, and blood–brain barrier (BBB) dysfunction, as crucial players involved in AD development. The critical role of lipids metabolism in the brain and its vascular barrier, and its constant modifications particularly throughout AD development, warrants investigation of brain lipid metabolism as a high value therapeutic target. Yet, there is limited knowledge on the biochemical and structural roles of lipids in BBB functionality in AD. Within this framework, we hypothesize that the ApoE4 genotype, strongly linked to AD risk and progression, may be related to altered fatty acids composition in the BBB. Interestingly, alpha linolenic acid (ALA), the precursor of the majoritarian brain component docosahexaenoic acid (DHA), emerges as a potential novel brain savior, acting via BBB functional improvements, and this may be primarily relevant to ApoE4 carriers.

1 May 2021 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
ALAlicia Leikin-Frenkel
Alicia Leikin-Frenkel
SLSigal Liraz-Zaltsman
Sigal Liraz-Zaltsman
KHKenneth S. Hollander
Kenneth S. Hollander
DADana Atrakchi
Dana Atrakchi
OROrly Ravid
Orly Ravid
ICItzik Cooper
Itzik Cooper